No connection

Search Results

Financial Score 35 Bullish

Evolv Technologies Stock Surges Amid Strong Q4 Results and Contract Wins

Apr 06, 2026 10:20 UTC
EVLV
Short term

Evolv Technologies' stock rose 14.2% in March and continued its upward trend in April, outperforming major indices. The defense sector company reported better-than-expected sales and raised its 2026 revenue guidance.

  • Evolv Technologies' stock surged 14.2% in March, outperforming the S&P 500 and Nasdaq Composite.
  • The company reported Q4 sales of $38.5 million, exceeding Wall Street estimates, and improved its net income to $10.9 million.
  • Evolv raised its 2026 revenue guidance to $172 million to $178 million and achieved $120.5 million in annual recurring revenue.
  • Contract extensions with the Tennessee Titans and Houston Astros, including the first AI weapons detection system in a baseball stadium, contributed to investor confidence.
  • Evolv's stock gained 6.2% in April, continuing its upward trend amid broader market gains linked to potential de-escalation in the Iran conflict.

Evolv Technologies (EVLV) delivered a notable stock performance in March, with its share price climbing 14.2% despite a broader market downturn. The S&P 500 and Nasdaq Composite fell 5.1% and 4.8%, respectively, during the same period. This outperformance was driven by the company's strong fourth-quarter results and optimistic forward guidance. Evolv reported Q4 sales of $38.5 million, exceeding Wall Street's $36.44 million estimate, although it posted an adjusted loss of $0.03 per share, slightly missing the expected $0.02 loss. The company's GAAP net income for the quarter was $10.9 million, a significant improvement from the $15.7 million net loss in the prior-year period. Annual recurring revenue (ARR) reached $120.5 million for the year, reflecting 21% year-over-year growth. In addition to its financial results, Evolv raised its 2026 revenue guidance to between $172 million and $178 million, up from the previous range of $160 million to $165 million. The company also announced contract extensions with the Tennessee Titans and Houston Astros, with the latter marking the first deployment of its AI-based weapons detection system in a professional baseball stadium. Evolv's stock has continued to rise in April, gaining approximately 6.2% as of the start of the month, outpacing the S&P 500's 3.8% and Nasdaq Composite's 5.2% gains. The broader market's recent recovery has been influenced by expectations of a potential de-escalation in the conflict with Iran, although recent statements from President Donald Trump hint at possible renewed volatility.

Sign up free to read the full analysis

Create a free account to unlock full AI-curated market articles, personalized alerts, and more.

Create Free Account Already have an account? Sign In
Share this article

Stay Ahead of the Markets

Join thousands of traders using AI-powered market intelligence. Get personalized insights, real-time alerts, and advanced analysis tools.

Get Started Free View Plans
Features Terminal AI Assistant Analysis Market News Pricing
Start Trading with AI Already have an account? Sign In
Home
Terminal
AI
Markets
Profile